William T. Andrews, M.D., FACP

2017

In 2017, William T. Andrews, M.D., FACP earned a total compensation of $1M as Chief Medical Officer at Opexa Therapeutics.

Compensation breakdown

Bonus$40,000
Option Awards$878,921
Salary$100,000
Total$1,018,921

FACP received $878.9K in option awards, accounting for 86% of the total pay in 2017.

FACP also received $40K in bonus and $100K in salary.

Rankings

In 2017, William T. Andrews, M.D., FACP's compensation ranked 8,894th out of 14,666 executives tracked by ExecPay. In other words, FACP earned more than 39.4% of executives.

ClassificationRankingPercentile
All
8,894
out of 14,666
39th
Division
Manufacturing
3,394
out of 5,768
41st
Major group
Chemicals And Allied Products
1,152
out of 2,074
45th
Industry group
Drugs
917
out of 1,730
47th
Industry
Pharmaceutical Preparations
719
out of 1,329
46th
Source: SEC filing on April 12, 2019.

FACP's colleagues

We found four more compensation records of executives who worked with William T. Andrews, M.D., FACP at Opexa Therapeutics in 2017.

2017

Neil Warma

Opexa Therapeutics

Chief Executive Officer

2017

William Andrews

Opexa Therapeutics

Chief Medical Officer

2017

Harry Palmin

Opexa Therapeutics

Chief Financial Officer

2017

Chris Schelling

Opexa Therapeutics

Chief Executive Officer

News

In-depth

You may also like